Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • FDA Advisory Warns More Than Two Dozen Varieties Of Over-The-Counter Eyedrops Linked To Risk Of Infection That Could Led To Blindness

    The AP (10/30) reports, “U.S. health regulators are warning consumers not to use more than two dozen varieties of over-the-counter eyedrops because of the risk of infections that could lead to blindness.” The FDA “advisory applies to lubricating drops sol...
    Full Article
  • COVID-19 Vaccination Not Linked To Incidence Of Graves Disease, Study Finds

    Endocrinology Advisor (10/30, Kuhns) reports, “COVID-19 vaccination is not associated with the incidence of Graves disease, according to study findings published in the Journal of Clinical Endocrinology and Metabolism.” In the study, “vaccination rates fo...
    Full Article
  • GSK’s RSV Vaccine Outselling Pfizer’s

    Reuters (10/30, Erman) reports, “Pfizer, which dominated COVID vaccine sales, now finds itself looking up at GSK, whose rival new respiratory syncytial virus (RSV) vaccine has surged to an early lead since the shots launched this summer.” Currently, “GSK...
    Full Article
  • HV.1 Now The Most Common COVID-19 Variant In US

    NBC News (10/27, Bendix) reported, “A new Covid variant has become dominant in the U.S., but relatively few people have thus far gotten the new shots that could offer some protection against it.” The HV.1 variant has “replaced EG.5 as the country’s most p...
    Full Article
  • Long-Term Use Of Doxycycline As Post-Exposure Prophylaxis Against Bacterial STIs Safe, Well-Tolerated, Study Finds

    Infectious Disease Advisor (10/27, Kuhns) reported, “Long-term use of doxycycline as post-exposure prophylaxis is safe and well tolerated, suggesting it may be appropriate as chemoprophylaxis against bacterial sexually transmitted infections (STIs).” In a...
    Full Article
  • Vibrio Cases, Deaths Spiked In Florida After Hurricane Ian Last Year

    Healio (10/27, Feller) reported, “Vibrio cases and deaths in Florida spiked last year after Hurricane Ian, lending credence to concerns that larger, longer, warmer tropical storms may increase the risk for viral infections, according to a study.” In the s...
    Full Article
  • Commercial Launch Of COVID-19 Treatments To Start November 1

    The AP (10/27, Seitz) reported COVID treatments, which are no longer covered by the government, “will enter the private market [this] week with a hefty price tag.” Pfizer is pricing a five-day course of Paxlovid (nirmatrelvir/ritonavir) “at $1,390, but Am...
    Full Article
  • Survey Finds Low Uptake Of New COVID-19 Vaccines

    The New York Times (10/27, Mandavilli) reported, “Few Americans have opted to be immunized against the coronavirus so far this fall: Just over 7 percent of adults and 2 percent of children had received a Covid-19 vaccine as of Oct. 14, according to a surv...
    Full Article
  • STDs On The Rise Across The Country, But Funding For Prevention Programs Getting Cut

    The AP (10/28, Hunter) reported, “Several states told The Associated Press that the biggest impact from having” federal funding for state STD prevention programs “canceled in the national debt ceiling deal is that they’re struggling to expand their diseas...
    Full Article
  • CDC Recommends New Meningococcal Disease Vaccine For Teens, Young Adults That Covers All Five Serotypes

    USA Today (10/26, Rodriguez) reports the CDC advisory panel on Wednesday recommended a new vaccine to protect teens against meningococcal disease, which “can cause hearing loss, severe neurological damage, the loss of limbs, and, in many cases, death.” Pr...
    Full Article
  • Risk For Multidrug- And Rifampicin-Resistant TB Recurrence Is Low Following Long-Term Treatment With Bedaquiline Or Delamanid, Study Finds

    Infectious Disease Advisor (10/26, Nye) reports, “The risk for multidrug (MDR)- and rifampicin-resistant tuberculosis (TB) recurrence is low following long-term treatment with bedaquiline or delamanid, according to results of a study published in Clinical...
    Full Article
  • Researchers Say Obesity Can Lead To Reduced Exposure, Response To ARVs Among Patients With HIV

    Healio (10/26, Stulpin) reports, “Using physiologically based pharmacokinetic modeling combined with observed clinical data, researchers determined that obesity can lead to reduced exposure and response to antiretroviral drugs” in people with HIV. In a st...
    Full Article
  • Pfizer, BioNTech Say Combination COVID-Flu Vaccine Generated Strong Immune Response In Trial

    Reuters (10/26, Mishra) reports, “Pfizer and German partner BioNTech said on Thursday that their vaccine to prevent flu and COVID-19 generated a strong immune response against strains of the viruses in an early- to mid-stage trial.” In the study, “the vac...
    Full Article
  • Men At High Risk For Mpox Infection Should Get Vaccinated Even After Current Outbreak Ends, CDC Advisers Say

    The AP (10/25, Stobbe) reports, “Gay and bisexual men at high risk for mpox infection should get vaccinated for the virus even after the current outbreak ends, government health advisers said Wednesday.” The recommendation by a panel of CDC advisers “now...
    Full Article
  • DOOR Analysis Can Be Adapted To Bacterial Pneumonia Clinical Trials, Researchers Say

    Healio (10/25, Stulpin) says, “Desirability of outcome ranking, or DOOR, can be adapted and used successfully in hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia clinical trials, researchers reported.” In a study publish...
    Full Article
  • High Level Of Herd Immunity, Vaccination May Be Needed To Prevent Future Hepatitis A Outbreaks Among People Who Inject Drugs, Study Finds

    Infectious Disease Advisor (10/25, Barowski) reports, “A relatively high level of herd immunity and vaccination coverage may be needed to prevent future outbreaks of hepatitis A virus (HAV) infection among people who inject drugs (PWID), according to stud...
    Full Article
  • Studies Evaluate Efficacy Of Simvastatin, Vitamin C In Treating Patients With COVID-19

    HealthDay (10/25, Murez) reports, “Clinical trials investigating use of two widely available products – vitamin C and the statin drug simvastatin – in critically ill COVID patients have yielded far different results.” In one study, published in the New En...
    Full Article
  • Advocacy Groups Urge Reauthorization Of PEPFAR

    The Hill (10/25, Choi) reports, “A bipartisan alliance of more than 30 health care groups and policy experts are calling on Congress to pass another 5-year reauthorization of the U.S. global HIV initiative, which expired last month.” The PEPFAR initiative...
    Full Article
  • FDA Accepts AstraZeneca’s Application For Self-Administered Nasal Flu Vaccine

    Reuters (10/24, Sunny) reports, “AstraZeneca said on Tuesday the U.S. Food and Drug Administration (FDA) has accepted for review the company’s application seeking approval for patients or caregivers to administer its nasal flu vaccine.” If approved, the F...
    Full Article
  • FDA Analysis Finds Co-Administration Of mRNA COVID-19 Vaccine, High-Dose Flu Vaccine Linked To Slightly Elevated Risk Of Stroke Among Older Adults

    The New York Times (10/24, Mandavilli) reports, “The Covid vaccines made by Pfizer-BioNTech and Moderna may be linked to a slight increase in the risk of stroke when administered along with a high-dose flu vaccine, according to a new analysis by the Food...
    Full Article
  • «
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id